Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
December 13, 2022
Patent Application Number
17116977
Date Filed
December 9, 2020
Patent Primary Examiner
Anti-heparanase compounds for the treatment of diabetes are described. The anti-heparanase compounds are high affinity, synthetic glycopolymers that result in minimal anticoagulant activity. Stereoselective fluorinated forms of these compounds are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
